Biomarker-adapted treatment in high-risk large B-cell lymphoma

Sirpa Leppä; Leo Meriranta; Maare Arffman; Judit Jorgensen; Marja-Liisa Karjalainen-Lindsberg; Klaus Beiske; Mette Pedersen; Kristina Drott; Annika Pasanen; Kristiina Karihtala; Susanna Mannisto; Bente Wold; Marianne Brodtkorb; Unn-Merete Fagerli; Thomas Stauffer Larsen; Lars Munksgaard; Kaisa Sunela; Oystein Fluge; Sirkku Jyrkkiö; Peter Brown; Harald Holte

doi:10.1002/hem3.70139

Biomarker-adapted treatment in high-risk large B-cell lymphoma

Sirpa Leppä, Leo Meriranta, Maare Arffman, Judit Jorgensen, Marja-Liisa Karjalainen-Lindsberg, Klaus Beiske, Mette Pedersen, Kristina Drott, Annika Pasanen, Kristiina Karihtala, Susanna Mannisto, Bente Wold, Marianne Brodtkorb, Unn-Merete Fagerli, Thomas Stauffer Larsen, Lars Munksgaard, Kaisa Sunela, Oystein Fluge, Sirkku Jyrkkiö, Peter BrownHarald Holte

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Artikelnummer	e70139
Tidskrift	Hemasphere
Volym	9
Nummer	5
Antal sidor	14
ISSN	2572-9241
DOI	https://doi.org/10.1002/hem3.70139
Status	Publicerad - maj 2025
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3122 Cancersjukdomar

Åtkomst av dokument

10.1002/hem3.70139

HemaSphere - 2025 - Leppä - Biomarker‐adapted treatment in high‐risk large B‐cell lymphomaSlutlig publicerad version, 1,68 MBLicens: CC BY-NC-ND

Citera det här

Leppä, S., Meriranta, L., Arffman, M., Jorgensen, J., Karjalainen-Lindsberg, M.-L., Beiske, K., Pedersen, M., Drott, K., Pasanen, A., Karihtala, K., Mannisto, S., Wold, B., Brodtkorb, M., Fagerli, U.-M., Larsen, T. S., Munksgaard, L., Sunela, K., Fluge, O., Jyrkkiö, S., ... Holte, H. (2025). Biomarker-adapted treatment in high-risk large B-cell lymphoma. Hemasphere, 9(5), Artikel e70139. https://doi.org/10.1002/hem3.70139

@article{873116beafa8481e87e91997765e3d5d,

title = "Biomarker-adapted treatment in high-risk large B-cell lymphoma",

keywords = "Rituximab plus cyclophosphamide, Health-organization classification, High-dose methotrexate, Phase-iii trial, R-chop, Single-arm, Front-line, Open-label, Tp53 gene, Chemotherapy, 3122 Cancers",

author = "Sirpa Lepp{\"a} and Leo Meriranta and Maare Arffman and Judit Jorgensen and Marja-Liisa Karjalainen-Lindsberg and Klaus Beiske and Mette Pedersen and Kristina Drott and Annika Pasanen and Kristiina Karihtala and Susanna Mannisto and Bente Wold and Marianne Brodtkorb and Unn-Merete Fagerli and Larsen, {Thomas Stauffer} and Lars Munksgaard and Kaisa Sunela and Oystein Fluge and Sirkku Jyrkki{\"o} and Peter Brown and Harald Holte",

year = "2025",

month = may,

doi = "10.1002/hem3.70139",

language = "English",

volume = "9",

journal = "Hemasphere",

issn = "2572-9241",

publisher = "Lippincott williams & wilkins",

number = "5",

}

Leppä, S, Meriranta, L, Arffman, M, Jorgensen, J, Karjalainen-Lindsberg, M-L, Beiske, K, Pedersen, M, Drott, K, Pasanen, A , Karihtala, K , Mannisto, S, Wold, B, Brodtkorb, M, Fagerli, U-M, Larsen, TS, Munksgaard, L, Sunela, K, Fluge, O, Jyrkkiö, S, Brown, P & Holte, H 2025, 'Biomarker-adapted treatment in high-risk large B-cell lymphoma', Hemasphere, vol. 9, nr. 5, e70139. https://doi.org/10.1002/hem3.70139

TY - JOUR

T1 - Biomarker-adapted treatment in high-risk large B-cell lymphoma

AU - Leppä, Sirpa

AU - Meriranta, Leo

AU - Arffman, Maare

AU - Jorgensen, Judit

AU - Karjalainen-Lindsberg, Marja-Liisa

AU - Beiske, Klaus

AU - Pedersen, Mette

AU - Drott, Kristina

AU - Pasanen, Annika

AU - Karihtala, Kristiina

AU - Mannisto, Susanna

AU - Wold, Bente

AU - Brodtkorb, Marianne

AU - Fagerli, Unn-Merete

AU - Larsen, Thomas Stauffer

AU - Munksgaard, Lars

AU - Sunela, Kaisa

AU - Fluge, Oystein

AU - Jyrkkiö, Sirkku

AU - Brown, Peter

AU - Holte, Harald

PY - 2025/5

Y1 - 2025/5

KW - Rituximab plus cyclophosphamide

KW - Health-organization classification

KW - High-dose methotrexate

KW - Phase-iii trial

KW - R-chop

KW - Single-arm

KW - Front-line

KW - Open-label

KW - Tp53 gene

KW - Chemotherapy

KW - 3122 Cancers

U2 - 10.1002/hem3.70139

DO - 10.1002/hem3.70139

M3 - Article

C2 - 40357216

SN - 2572-9241

VL - 9

JO - Hemasphere

JF - Hemasphere

IS - 5

M1 - e70139

ER -